Cannabis Law Report

DECEMBER 9, 2021

A 4-year-old Texas Original Compassionate Cultivation patient improves seizure control, behaviors and sleep with the company’s medicine. After working with Carter’s neurologist to balance TXOG’s medicine with other treatments, they noticed a difference in seizure reduction as well as improved behavioral control and sleep.

Conditions 40

Conditions Patients Sleep Medicine 40

Veriheal

JULY 22, 2020

While this is a price worth paying to many as cannabis provides relief when many traditional treatments and medicines have failed, it is out of reach for many. For many PTSD veteran patients, to obtain the amount of cannabis products required to medicate each day, it would cost around $50 a day.

Legalization 69

Legalization Programs Banking Conditions 69

Cannabis Law Report

JUNE 23, 2021

The analysis of patient-reported outcome measures following treatment with cannabis-based medicinal products (CBMPs) in a study covering patients with all conditions found statistically significant improvements in anxiety, sleep , and general quality of life at one, three, and six months following treatment, compared to baseline assessment.

Cannabinoids 45

Cannabinoids Data Chronic Pain Sleep 45

MMJ Recs

OCTOBER 31, 2023

In West Virginia, the journey to MMJ access has been characterized by progress, patient advocacy, and a commitment to enhancing the quality of life for those in need. She had tried numerous treatments without much success until she explored the option of MMJ. I had difficulty going out, meeting people, and even sleeping.

Access 52

Access Programs Patients Dispensary 52

Cannabis Law Report

OCTOBER 14, 2021

formerly the Canadian Association of Retired Persons), Canada’s largest advocacy association for Canadians As We Age. Understanding the utility of medical cannabis is increasingly important to older Canadians for the treatment of conditions including chronic pain, anxiety and lack of sleep. ’s advocacy.

Advocacy 40

Advocacy Research and Development Chronic Pain Pharmaceutical 40

Cannabis Law Report

APRIL 12, 2019

I use medical cannabis for my skin, pain, mood, fatigue, appetite and, most importantly, sleep. We aim to continue to do more for the Canadian patients who choose to use medical cannabis as a treatment option. Patient advocacy is alive and well in Canada.

Access 45

Access Patients Marijuana Medicine 45

Cannabis Law Report

MARCH 13, 2019

She teaches trial advocacy for the Notre Dame Law School and has coached trial team for Chicago-Kent Law School. Walmart’s policy also required employees to submit to a drug or alcohol test if they suffered a workplace injury that required medical treatment. In addition to her extensive litigation practice, Ms. During law school, Ms.

Marijuana 45

Marijuana Policy Advocacy State Laws 45

The Cannigma

DECEMBER 22, 2021

I mean, I’m listening to that list and two things that are really obvious for me that I’m missing there is sleep, like sleep disorders and anxiety. IR: It would be going under pain, yes. I suppose, these would be the two next things you’d want to see add in. That’s part of the tension within the market.

Research and Development 98

Research and Development Oil Cannabis Clinical Trials 98

Cannabis Law Report

SEPTEMBER 23, 2019

The AAFP urges its members to be involved in the diagnosis, treatment, and prevention of substance use, as well as secondary diseases impacted or caused by use. The AAFP recognizes the benefits of intervention and treatment for the recreational use of marijuana, in lieu of incarceration, for all individuals, including youth.

Cannabinoids 40

Cannabinoids Marijuana Research and Development Access 40

Cannabis Law Report

JULY 30, 2019

Usage of over-the-counter pain relievers and sleep aids, as well as prescription pain relievers and anti-anxiety medications dropped” . That a patient had exhausted all other “recognized traditional treatment options available for condition” before turning to medical cannabis as a therapeutic medicinal treatment. .

Marijuana 45

Marijuana Patients Research and Development Programs 45

Cannabis Law Report

NOVEMBER 24, 2021

It was also used as a topical treatment for haemorrhoids, ear infection, and wounds (Aldrich 1997 ; Touw 1981 ). The latter remains a dangerous drug and is considered higher risk for treatment than CBD (TGA 2019 ). Less frequent were references to multiple sclerosis, anxiety and depression, sleep, and HIV. Full size image.

Research and Development 52

Research and Development Medicine Access Media 52

Veriheal

AUGUST 31, 2021

Essay Summary: Sandeep conceptualizes a strain recommendation app in which consumers can create a profile and review strains and their effects (help with sleep, back pain, migraines, etc.). Major/Program: Business Administration. Like a dating app, consumers would be matched to dispensaries with strains matching their preferences and needs.

Research and Development 119

Research and Development Supply Chain Programs Education 119

The Cannigma

FEBRUARY 16, 2022

We always have a nice little tidbit when we’re all about advocacy and access to cannabis for all. Is this as needed for sleep? They’re college athletes, or they’re not sleeping, their bodies aren’t recovering. EG: All right, so that’s going to be straight up to the interview.

Trichome 98

Trichome Wellness and Beauty Cannabinoids Cannabis 98

The Cannigma

DECEMBER 12, 2022

Scientists are hopeful that psychedelics might have more of a curative effect when it comes to mental health than many existing treatment options; meaning that unlike most psychiatric medications, psychedelics may be able to prompt long-term changes to our mental state with only a few doses. Are psychedelics safe?

History 141

History Microdosing Research and Development Clinical Trials 141

Cannabis Law Report

SEPTEMBER 22, 2019

Knowing Your Rights , provided by the national medical cannabis advocacy organization Americans for Safe Access, admonishes current cannabis consumers: Medical cannabis patients and their providers are vulnerable to federal and state raids, arrest, prosecution, and incarceration. PERSONAL RIGHTS.

Cannabis 45

Cannabis Access Patients Legalization 45

The Cannigma

JANUARY 19, 2022

The resulting prejudice can often discourage folks from seeking out medical cannabis as an option, and can even affect state legislature, forcing patients to overcome unnecessary and prohibitive obstacles in order to receive the treatment they need. Nikki’s story is deeply inspirational, and we are honored to have had her on the show.

Patients 98

Patients Compliance Compliance Cannabis 98

Cannabis Law Report

JUNE 4, 2021

there has never been a better time for new treatment options. David John Nutt is an English neuropsychopharmacologist specialising in the research of drugs that affect the brain and conditions such as addiction, anxiety, and sleep. Healing Advocacy Fund. Drug Science. Matthew Johnson. Johns Hopkins University. Sam Chapman.

Research and Development 51

Research and Development Medicine Pharmaceutical Treatment 51